With reference to the earlier announcement dated April 25, 2014 regarding Q4 & FY14 results wherein the discrepancies in Part II (Shareholding Details) of the Financial Result for the quarter and year ended March 31, 2014. In this regard, Biocon has now informed that difference in numbers under Particulars of Shareholders in the column pertaining to year ended March 31, 2014 was due to typographical mistake. The correct numbers were however carried in the consolidated financial results as intimated to the Stock Exchanges. The Company has rectified the Shareholding details [Part II] information in the Standalone results.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: